10.1007/s40097-022-00493-2

Nanoscale metal–organic frameworks as smart nanocarriers for cancer therapy

  • Yang Liu1,
  • Pengfei Lei2,
  • Xuewei Liao*3,
  • Chen Wang4,
  1. School of Environment, Nanjing Normal University, Nanjing, 210023, CN
  2. Department of Orthopedic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, CN
  3. Analytical and Testing Center, Nanjing Normal University, Nanjing, 210023, CN
  4. College of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, CN
Nanoscale metal–organic frameworks as smart nanocarriers for cancer therapy

Published in Issue 01-06-2022

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Liu, Y., Lei, P., Liao, X., & Wang, C. (2022). Nanoscale metal–organic frameworks as smart nanocarriers for cancer therapy. Journal of Nanostructure in Chemistry, 14(1 (February 2024). https://doi.org/10.1007/s40097-022-00493-2
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Abstract Cancer is one of the serious diseases to human life. Early and precise cancer diagnosis and timely therapy are in urgent need nowadays. Due to the advantages of porous structures and tunable properties, metal–organic frameworks (MOFs) are becoming type of rapidly developing and attractive supports used in biomedicine, which have been widely applied in the fields of chemistry, biology, materials science, etc. Particularly, nanoscale MOFs (nMOFs) with more accessible active sites and improved stability are ideal platforms for biological and clinical applications in vitro and in vivo. This review article summarizes the recent progresses in nMOFs based nanoplatforms for drug delivery and cancer therapy. Different techniques using nMOFs are systematically summarized including chemotherapy, photodynamic therapy (PDT), photothermal therapy (PTT), chemodynamic therapy (CDT), radiotherapy (RT), and the combined therapy methods. Finally, a brief conclusion and outlook for biomedical applications of this special field is provided. We expect this review could be helpful for future designing and fabrication of multi-functional nMOFs platforms for drug delivery, disease therapy, and other biomedical applications.

Keywords

  • Nanoscale metal–organic frameworks (nMOFs),
  • Nanocarrier,
  • Drug delivery,
  • Cancer therapy,
  • Biomedicine

References

  1. Coussens and Werb (2002) Inflammation and cancer (pp. 860-867) https://doi.org/10.1038/nature01322
  2. Zhang et al. (2020) Cancer diagnosis with DNA molecular computation (pp. 709-715) https://doi.org/10.1038/s41565-020-0699-0
  3. Li et al. (1999) Design and synthesis of an exceptionally stable and highly porous metal-organic framework (pp. 276-279) https://doi.org/10.1038/46248
  4. Jin et al. (2021) Redox-responsive micelles integrating catalytic nanomedicine and selective chemotherapy for effective tumor treatment (pp. 3076-3082) https://doi.org/10.1016/j.cclet.2021.03.084
  5. Yang et al. (2021) Molecular-scale drug delivery systems loaded with oxaliplatin for supramolecular chemotherapy (pp. 729-734) https://doi.org/10.1016/j.cclet.2020.08.035
  6. Anbia and Faryadras (2015) In situ Na center dot Cu-3(BTC)(2) and Li center dot Cu-3(BTC)(2) nanoporous MOFs synthesis for enhancing H-2 storage at ambient temperature (pp. 357-364) https://doi.org/10.1007/s40097-015-0167-9
  7. Yang et al. (2019) Boosting the photodynamic therapy efficiency with a mitochondria-targeted nanophotosensitizer (pp. 1293-1296) https://doi.org/10.1016/j.cclet.2019.03.032
  8. Ghiamaty et al. (2016) Synthesis of palladium-carbon nanotube-metal organic framework composite and its application as electrocatalyst for hydrogen production (pp. 299-308) https://doi.org/10.1007/s40097-016-0203-4
  9. Wu et al. (2020) A photosensitizer-loaded zinc oxide-polydopamine core-shell nanotherapeutic agent for photodynamic and photothermal synergistic therapy of cancer cells (pp. 189-192) https://doi.org/10.1016/j.cclet.2019.05.004
  10. Rodriguez et al. (2020) Synthesis of highly stable κ/ι-hybrid carrageenan micro- and nanogels via a sonication-assisted microemulsion route (pp. 69-82)
  11. Makvandi et al. (2021) Endocytosis of abiotic nanomaterials and nanobiovectors: inhibition of membrane trafficking https://doi.org/10.1016/j.nantod.2021.101279
  12. Gulla et al. (2021) Titanium dioxide nanotubes conjugated with quercetin function as an effective anticancer agent by inducing apoptosis in melanoma cells (pp. 721-734) https://doi.org/10.1007/s40097-021-00396-8
  13. Tabasi et al. (2021) Metal–polymer-coordinated complexes as potential nanovehicles for drug delivery https://doi.org/10.1007/s40097-021-00432-7
  14. Eivazzadeh-Keihan and Maleki (2021) Design and synthesis of a new magnetic aromatic organo-silane star polymer with unique nanoplate morphology and hyperthermia application https://doi.org/10.1007/s40097-021-00401-0
  15. Nasri et al. (2020) Thymoquinone-loaded ethosome with breast cancer potential: optimization, in vitro and biological assessment (pp. 19-31) https://doi.org/10.1007/s40097-019-00325-w
  16. Kong et al. (2020) A green-emission metal-organic framework-based nanoprobe for imaging dual tumor biomarkers in living cells (pp. 35375-35384) https://doi.org/10.1021/acsami.0c10038
  17. Ma et al. (2019) Functional metal organic framework/SiO2 nanocomposites: from versatile synthesis to advanced applications https://doi.org/10.3390/polym11111823
  18. Liu et al. (2020) Core-shell nanosystems for self-activated drug-gene combinations against triple-negative breast cancer (pp. 53654-53664) https://doi.org/10.1021/acsami.0c15089
  19. Shu et al. (2020) Stretchable electrochemical biosensing platform based on Ni-MOF composite/Au nanoparticle-coated carbon nanotubes for real-time monitoring of dopamine released from living cells (pp. 49480-49488) https://doi.org/10.1021/acsami.0c16060
  20. Hu et al. (2021) Cytotoxicity of aptamer-conjugated chitosan encapsulated mycogenic gold nanoparticles in human lung cancer cells https://doi.org/10.1007/s40097-021-00437-2
  21. Rehman et al. (2020) Investigation of ROS scavenging properties and in vitro cytotoxicity of oxygen-deficient La2O3−x nanostructure synthesized by spray pyrolysis method (pp. 347-361) https://doi.org/10.1007/s40097-020-00356-8
  22. Yang et al. (2012) Functionalized mesoporous silica materials for controlled drug delivery (pp. 3679-3698) https://doi.org/10.1039/c2cs15308d
  23. Tabasi et al. (2021) Metal-polymer-coordinated complexes as potential nanovehicles for drug delivery (pp. 501-526) https://doi.org/10.1007/s40097-021-00432-7
  24. Xu et al. (2021) Recent advances in nanoscale metal-organic frameworks biosensors for detection of biomarkers https://doi.org/10.1016/j.cclet.2021.06.015
  25. Duman and Forgan (2021) Applications of nanoscale metal-organic frameworks as imaging agents in biology and medicine (pp. 3423-3449) https://doi.org/10.1039/D1TB00358E
  26. Zhang et al. (2020) Metal-organic framework-based nanomaterials for biomedical applications (pp. 1060-1070) https://doi.org/10.1016/j.cclet.2019.11.036
  27. Rojas et al. (2017) Metal organic frameworks based on bioactive components (pp. 2560-2573) https://doi.org/10.1039/C6TB03217F
  28. Castillo-Blas et al. (2020) The role of defects in the properties of functional coordination polymers (pp. 73-119) https://doi.org/10.1016/bs.adioch.2020.03.002
  29. Peng et al. (2012) Surfactant-directed assembly of mesoporous metal-organic framework nanoplates in ionic liquids (pp. 8688-8690) https://doi.org/10.1039/c2cc34416e
  30. Zheng et al. (2017) Controllable preparation of nanoscale metal-organic frameworks by ionic liquid microemulsions (pp. 5899-5905) https://doi.org/10.1021/acs.iecr.7b00694
  31. Zhang et al. (2020) pH-Responsive metal-organic framework encapsulated gold nanoclusters with modulated release to enhance photodynamic therapy/chemotherapy in breast cancer (pp. 1739-1747) https://doi.org/10.1039/C9TB02621E
  32. Zhang et al. (2019) A non-enzymatic glucose sensor with enhanced anti-interference ability based on a MIL-53(NiFe) metal-organic framework (pp. 7006-7013) https://doi.org/10.1039/C9TB01832H
  33. Huang et al. (2021) Nanoscale metal-organic frameworks for tumor phototherapy (pp. 3756-3777) https://doi.org/10.1039/D1TB00349F
  34. Lei et al. (2018) Constructing redox-responsive metal–organic framework nanocarriers for anticancer drug delivery (pp. 16698-16706) https://doi.org/10.1021/acsami.7b19693
  35. He et al. (2019) A catalase-like metal-organic framework nanohybrid for O2-evolving synergistic chemoradiotherapy (pp. 8752-8756) https://doi.org/10.1002/anie.201902612
  36. Su et al. (2021) Determination of acetamiprid by fluorescence monitoring of a glycine-l-histidine copper-organic framework aptasensor https://doi.org/10.1080/00032719.2021.1946555
  37. Cai et al. (2019) Biological metal-organic frameworks: Structures, host-guest chemistry and bio-applications (pp. 207-221) https://doi.org/10.1016/j.ccr.2017.12.003
  38. Zhu and Liu (2019) The synthetic strategies of metal-organic framework membranes, films and 2D MOFs and their applications in devices (pp. 21004-21035) https://doi.org/10.1039/C9TA05383B
  39. He et al. (2019) Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy (pp. 1343-1365) https://doi.org/10.2217/nnm-2018-0347
  40. Zhou et al. (2018) Nanoscaled metal-organic frameworks for biosensing, imaging, and cancer therapy https://doi.org/10.1002/adhm.201800022
  41. Zhang et al. (2016) Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy https://doi.org/10.1038/ncomms12619
  42. Ren et al. (2014) Polyacrylic acid@zeolitic imidazolate framework-8 nanoparticles with ultrahigh drug loading capability for pH-sensitive drug release (pp. 1000-1002) https://doi.org/10.1039/C3CC47666A
  43. Zhu et al. (2021) Synergistic effects of rapamycin and fluorouracil to treat a gastric tumor in a PTEN conditional deletion mouse model https://doi.org/10.1007/s10120-021-01229-x
  44. Kiss et al. (2021) Targeting DNA damage response and repair to enhance therapeutic index in cisplatin-based cancer treatment https://doi.org/10.3390/ijms22158199
  45. Zheng et al. (2021) Self-assembled pH-sensitive nanoparticles based on ganoderma lucidum polysaccharide-methotrexate conjugates for the co-delivery of anti-tumor drugs (pp. 3764-3773) https://doi.org/10.1021/acsbiomaterials.1c00663
  46. Allen and Cullis (2004) Drug delivery systems: entering the mainstream (pp. 1818-1822) https://doi.org/10.1126/science.1095833
  47. Sosnik and Menaker Raskin (2015) Polymeric micelles in mucosal drug delivery: challenges towards clinical translation (pp. 1380-1392) https://doi.org/10.1016/j.biotechadv.2015.01.003
  48. Du et al. (2015) Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo (pp. 1-11) https://doi.org/10.1016/j.biomaterials.2015.07.048
  49. Gong et al. (2019) Highly fluorescent N-doped carbon dots with two-photon emission for ultrasensitive detection of tumor marker and visual monitor anticancer drug loading and delivery (pp. 994-1002) https://doi.org/10.1016/j.cej.2018.09.100
  50. Wang et al. (2015) Mesoporous silica nanoparticles in drug delivery and biomedical applications (pp. 313-327) https://doi.org/10.1016/j.nano.2014.09.014
  51. Horcajada et al. (2008) Flexible porous metal-organic frameworks for a controlled drug delivery (pp. 6774-6780) https://doi.org/10.1021/ja710973k
  52. Horcajada et al. (2010) Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging (pp. 172-178) https://doi.org/10.1038/nmat2608
  53. Cai and Jiang (2017) A modulator-induced defect-formation strategy to hierarchically porous metal-organic frameworks with high stability (pp. 563-567) https://doi.org/10.1002/anie.201610914
  54. Wang et al. (2020) Metal-organic frameworks for stimuli-responsive drug delivery https://doi.org/10.1016/j.biomaterials.2019.119619
  55. Orellana-Tavra et al. (2015) Amorphous metal-organic frameworks for drug delivery (pp. 13878-13881) https://doi.org/10.1039/C5CC05237H
  56. Teplensky et al. (2017) Temperature treatment of highly porous zirconium-containing metal–organic frameworks extends drug delivery release (pp. 7522-7532) https://doi.org/10.1021/jacs.7b01451
  57. Wang et al. (2019) MOFBOTS: metal–organic-framework-based biomedical microrobots https://doi.org/10.1002/adma.201901592
  58. Liang et al. (2018) A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery (pp. 10223-10228) https://doi.org/10.1039/C8DT01789A
  59. Jia et al. (2019) A γ-cyclodextrin-based metal-organic framework embedded with graphene quantum dots and modified with PEGMA via SI-ATRP for anticancer drug delivery and therapy (pp. 20956-20967) https://doi.org/10.1039/C9NR06195A
  60. Kahn et al. (2017) Stimuli-responsive DNA-functionalized metal-organic frameworks (MOFs) https://doi.org/10.1002/adma.201602782
  61. Mura et al. (2013) Stimuli-responsive nanocarriers for drug delivery (pp. 991-1003) https://doi.org/10.1038/nmat3776
  62. Liu et al. (2019) In situ polymerization on nanoscale metal-organic frameworks for enhanced physiological stability and stimulus-responsive intracellular drug delivery https://doi.org/10.1016/j.biomaterials.2019.119365
  63. Min et al. (2019) Biomimetic metal–organic framework nanoparticles for cooperative combination of antiangiogenesis and photodynamic therapy for enhanced efficacy https://doi.org/10.1002/adma.201808200
  64. Ranji-Burachaloo et al. (2019) Combined fenton and starvation therapies using hemoglobin and glucose oxidase (pp. 5705-5716) https://doi.org/10.1039/C8NR09107B
  65. Kim et al. (2019) MOF × biopolymer: collaborative combination of metal-organic framework and biopolymer for advanced anticancer therapy (pp. 27512-27520) https://doi.org/10.1021/acsami.9b05736
  66. Yang et al. (2019) Nanoscale ATP-responsive zeolitic imidazole framework-90 as a general platform for cytosolic protein delivery and genome editing (pp. 3782-3786) https://doi.org/10.1021/jacs.8b11996
  67. Chen et al. (2017) ATP-responsive aptamer-based metal-organic framework nanoparticles (NMOFs) for the controlled release of loads and drugs https://doi.org/10.1002/adfm.201702102
  68. Ma et al. (2017) H2S-activable MOF nanoparticle photosensitizer for effective photodynamic therapy against cancer with controllable singlet-oxygen release (pp. 13752-13756) https://doi.org/10.1002/anie.201708005
  69. Cheung and Li (2021) Development of self-care textile wearables with thermally stimulated drug delivery function via biological and physical investigations (pp. 820-827) https://doi.org/10.1177/0040517520960758
  70. Fernandez and Orozco (2021) Advances in functionalized photosensitive polymeric nanocarriers https://doi.org/10.3390/polym13152464
  71. Wu et al. (2021) Pressure-driven spreadable deferoxamine-laden hydrogels for vascularized skin flaps dagger (pp. 3162-3170) https://doi.org/10.1039/D1BM00053E
  72. Jiang et al. (2017) Thermal stimuli-triggered drug release from a biocompatible porous metal–organic framework (pp. 10215-10221) https://doi.org/10.1002/chem.201701904
  73. Roth Stefaniak et al. (2018) Photo-triggered release of 5-fluorouracil from a MOF drug delivery vehicle (pp. 7617-7620) https://doi.org/10.1039/C8CC01601A
  74. Lin et al. (2020) Acetaldehyde-modified-cystine functionalized Zr-MOFs for pH/GSH dual-responsive drug delivery and selective visualization of GSH in living cells (pp. 3084-3091) https://doi.org/10.1039/C9RA05741B
  75. Li et al. (2018) Coordination-responsive drug release inside gold nanorod@metal-organic framework core–shell nanostructures for near-infrared-induced synergistic chemo-photothermal therapy (pp. 3294-3305) https://doi.org/10.1007/s12274-017-1874-y
  76. Ng and Zheng (2015) Molecular interactions in organic nanoparticles for phototheranostic applications (pp. 11012-11042) https://doi.org/10.1021/acs.chemrev.5b00140
  77. Yoon et al. (2013) Advance in photosensitizers and light delivery for photodynamic therapy (pp. 7-23) https://doi.org/10.5946/ce.2013.46.1.7
  78. Lovell et al. (2010) Activatable photosensitizers for imaging and therapy (pp. 2839-2857) https://doi.org/10.1021/cr900236h
  79. Agostinis et al. (2011) Photodynamic therapy of cancer: an update (pp. 250-281) https://doi.org/10.3322/caac.20114
  80. Chatterjee et al. (2008) Nanoparticles in photodynamic therapy: an emerging paradigm (pp. 1627-1637) https://doi.org/10.1016/j.addr.2008.08.003
  81. Dolmans et al. (2003) Photodynamic therapy for cancer (pp. 380-387) https://doi.org/10.1038/nrc1071
  82. Lismont et al. (2017) Metal-organic framework nanoparticles in photodynamic therapy: current status and perspectives https://doi.org/10.1002/adfm.201606314
  83. Secret et al. (2014) Two-photon excitation of porphyrin-functionalized porous silicon nanoparticles for photodynamic therapy (pp. 7643-7648) https://doi.org/10.1002/adma.201403415
  84. Konan et al. (2002) State of the art in the delivery of photosensitizers for photodynamic therapy (pp. 89-106) https://doi.org/10.1016/S1011-1344(01)00267-6
  85. Chouikrat et al. (2012) Non-polymeric nanoparticles for photodynamic therapy applications: recent developments (pp. 781-792) https://doi.org/10.2174/092986712799034897
  86. Lu et al. (2014) Nanoscale metal–organic framework for highly effective photodynamic therapy of resistant head and neck cancer (pp. 16712-16715) https://doi.org/10.1021/ja508679h
  87. Lu et al. (2015) A chlorin-based nanoscale metal–organic framework for photodynamic therapy of colon cancers (pp. 7600-7603) https://doi.org/10.1021/jacs.5b04069
  88. Carvalho et al. (2013) Tetrabenzoporphyrins: synthetic developments and applications (pp. 3302-3317) https://doi.org/10.1039/c3cs35500d
  89. Liu et al. (2017) Dual-stage light amplified photodynamic therapy against hypoxic tumor based on an O2 self-sufficient nanoplatform https://doi.org/10.1002/smll.201701621
  90. Gao et al. (2018) Biomimetic O2-evolving metal-organic framework nanoplatform for highly efficient photodynamic therapy against hypoxic tumor (pp. 83-94) https://doi.org/10.1016/j.biomaterials.2018.06.007
  91. Liu et al. (2019) Metal–organic framework (MOF) hybrid as a tandem catalyst for enhanced therapy against hypoxic tumor cells (pp. 7808-7812) https://doi.org/10.1002/anie.201903475
  92. Zhang et al. (2018) Nanozyme decorated metal–organic frameworks for enhanced photodynamic therapy (pp. 651-661) https://doi.org/10.1021/acsnano.7b07746
  93. Zheng et al. (2016) Carbon-dot-decorated carbon nitride nanoparticles for enhanced photodynamic therapy against hypoxic tumor via water splitting (pp. 8715-8722) https://doi.org/10.1021/acsnano.6b04156
  94. Cairns et al. (2011) Regulation of cancer cell metabolism (pp. 85-95) https://doi.org/10.1038/nrc2981
  95. Chen et al. (2019) Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells (pp. 498-510) https://doi.org/10.1038/s41556-019-0299-0
  96. Li et al. (2017) Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy (pp. 7006-7018) https://doi.org/10.1021/acsnano.7b02533
  97. Chen et al. (2016) Lactate metabolism is associated with mammalian mitochondria (pp. 937-943) https://doi.org/10.1038/nchembio.2172
  98. Chen et al. (2018) Interfering with lactate-fueled respiration for enhanced photodynamic tumor therapy by a porphyrinic MOF nanoplatform https://doi.org/10.1002/adfm.201803498
  99. He et al. (2020) Solvent-assisted self-assembly of a metal–organic framework based biocatalyst for cascade reaction driven photodynamic therapy (pp. 6822-6832) https://doi.org/10.1021/jacs.0c02497
  100. Cramer et al. (2017) Systemic depletion of l-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth (pp. 120-127) https://doi.org/10.1038/nm.4232
  101. Cheng et al. (2019) Nanotherapeutics interfere with cellular redox homeostasis for highly improved photodynamic therapy https://doi.org/10.1016/j.biomaterials.2019.119500
  102. Zhang et al. (2018) Enhanced photodynamic therapy by reduced levels of intracellular glutathione obtained by employing a nano-MOF with CuII as the active center (pp. 4891-4896) https://doi.org/10.1002/anie.201710800
  103. Wang et al. (2019) Specific generation of singlet oxygen through the Russell mechanism in hypoxic tumors and GSH depletion by Cu-TCPP nanosheets for cancer therapy (pp. 9846-9850) https://doi.org/10.1002/anie.201903981
  104. Miyamoto et al. (2014) Singlet molecular oxygen generated by biological hydroperoxides (pp. 24-33) https://doi.org/10.1016/j.jphotobiol.2014.03.028
  105. Melancon et al. (2011) Cancer theranostics with near-infrared light-activatable multimodal nanoparticles (pp. 947-956) https://doi.org/10.1021/ar200022e
  106. Dykman and Khlebtsov (2012) Gold nanoparticles in biomedical applications: recent advances and perspectives (pp. 2256-2282) https://doi.org/10.1039/C1CS15166E
  107. Tian et al. (2011) Hydrophilic flower-like CuS superstructures as an efficient 980 nm laser-driven photothermal agent for ablation of cancer cells (pp. 3542-3547) https://doi.org/10.1002/adma.201101295
  108. Yang et al. (2013) Nano-graphene in biomedicine: theranostic applications (pp. 530-547) https://doi.org/10.1039/C2CS35342C
  109. Zhu et al. (2016) PPy@MIL-100 nanoparticles as a pH- and near-IR-irradiation-responsive drug carrier for simultaneous photothermal therapy and chemotherapy of cancer cells (pp. 34209-34217) https://doi.org/10.1021/acsami.6b11378
  110. Jiang et al. (2018) CuS@MOF-based well-designed quercetin delivery system for chemo–photothermal therapy (pp. 34513-34523) https://doi.org/10.1021/acsami.8b13487
  111. Keerthiga et al. (2020) Photodynamic nanophotosensitizers: promising materials for tumor theranostics (pp. 5474-5485) https://doi.org/10.1021/acsbiomaterials.0c01058
  112. Wang et al. (2018) In situ one-pot synthesis of MOF–polydopamine hybrid nanogels with enhanced photothermal effect for targeted cancer therapy https://doi.org/10.1002/advs.201800287
  113. Li et al. (2018) Ultrathin Cu-TCPP MOF nanosheets: a new theragnostic nanoplatform with magnetic resonance/near-infrared thermal imaging for synergistic phototherapy of cancers (pp. 4086-4096) https://doi.org/10.7150/thno.25433
  114. Zhang et al. (2016) Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized fenton reaction (pp. 2101-2106) https://doi.org/10.1002/anie.201510031
  115. Tang et al. (2019) Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions (pp. 946-956) https://doi.org/10.1002/anie.201805664
  116. Zhang et al. (2018) An adenosine triphosphate-responsive autocatalytic fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe(III)/Fe(II) conversion (pp. 7609-7618) https://doi.org/10.1021/acs.nanolett.8b03178
  117. Yu et al. (2021) Hydrogen peroxide-generating nanomedicine for enhanced chemodynamic therapy (pp. 2127-2138) https://doi.org/10.1016/j.cclet.2021.02.015
  118. Liou and Storz (2010) Reactive oxygen species in cancer (pp. 479-496) https://doi.org/10.3109/10715761003667554
  119. Zhang et al. (2019) Positive feedback nanoamplifier responded to tumor microenvironments for self-enhanced tumor imaging and therapy https://doi.org/10.1016/j.biomaterials.2019.119255
  120. Wang et al. (2016) Magnetically guided delivery of DHA and Fe ions for enhanced cancer therapy based on pH-responsive degradation of DHA-loaded Fe3O4@C@MIL-100(Fe) nanoparticles (pp. 88-101) https://doi.org/10.1016/j.biomaterials.2016.08.039
  121. Xue et al. (2019) Doxorubicin-loaded nanoscale metal–organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy (pp. 4615-4623) https://doi.org/10.1039/C9BM01044K
  122. Wang et al. (2014) Ferrocene-catalyzed heterogeneous fenton-like degradation of methylene blue: influence of initial solution pH (pp. 6334-6340) https://doi.org/10.1021/ie500115j
  123. Ornelas (2011) Application of ferrocene and its derivatives in cancer research (pp. 1973-1985) https://doi.org/10.1039/c1nj20172g
  124. Jaouen et al. (2015) Ferrocifen type anticancer drugs (pp. 8802-8817) https://doi.org/10.1039/C5CS00486A
  125. Fang et al. (2020) Co–ferrocene MOF/glucose oxidase as cascade nanozyme for effective tumor therapy https://doi.org/10.1002/adfm.201910085
  126. Ranji-Burachaloo et al. (2017) MOF-mediated destruction of cancer using the cell’s own hydrogen peroxide (pp. 33599-33608) https://doi.org/10.1021/acsami.7b07981
  127. Brenner and Ward (1992) Constraints on energy deposition and target size of multiply damaged sites associated with DNA double-strand breaks (pp. 737-748) https://doi.org/10.1080/09553009214551591
  128. Song et al. (2017) Emerging nanotechnology and advanced materials for cancer radiation therapy https://doi.org/10.1002/adma.201700996
  129. Pallares and Abergel (2020) Nanoparticles for targeted cancer radiotherapy (pp. 2887-2897) https://doi.org/10.1007/s12274-020-2957-8
  130. Li et al. (2020) Nanoscale metal-organic frameworks: synthesis, biocompatibility, imaging applications, and thermal and dynamic therapy of tumors https://doi.org/10.1002/adfm.201908924
  131. Ma et al. (2019) Quercetin-modified metal–organic frameworks for dual sensitization of radiotherapy in tumor tissues by inhibiting the carbonic anhydrase IX (pp. 4209-4219) https://doi.org/10.1021/acsnano.8b09221
  132. Wang et al. (2014) Synergistic assembly of heavy metal clusters and luminescent organic bridging ligands in metal–organic frameworks for highly efficient X-ray scintillation (pp. 6171-6174) https://doi.org/10.1021/ja500671h
  133. Misawa and Takahashi (2011) Generation of reactive oxygen species induced by gold nanoparticles under X-ray and UV irradiations (pp. 604-614) https://doi.org/10.1016/j.nano.2011.01.014
  134. Song et al. (2017) TaOx decorated perfluorocarbon nanodroplets as oxygen reservoirs to overcome tumor hypoxia and enhance cancer radiotherapy (pp. 257-263) https://doi.org/10.1016/j.biomaterials.2016.10.020
  135. Zhu et al. (2018) Recent progress in the development of near-infrared organic photothermal and photodynamic nanotherapeutics (pp. 746-765) https://doi.org/10.1039/C7BM01210A
  136. Gong et al. (2014) Engineering of multifunctional nano-micelles for combined photothermal and photodynamic therapy under the guidance of multimodal imaging (pp. 6492-6502) https://doi.org/10.1002/adfm.201401451
  137. Gai et al. (2018) Recent advances in functional nanomaterials for light–triggered cancer therapy (pp. 146-187) https://doi.org/10.1016/j.nantod.2018.02.010
  138. Wang et al. (2019) Exploiting single atom iron centers in a porphyrin-like MOF for efficient cancer phototherapy (pp. 35228-35237) https://doi.org/10.1021/acsami.9b11238
  139. Zhang et al. (2018) Metal–organic framework nanoshuttle for synergistic photodynamic and low-temperature photothermal therapy https://doi.org/10.1002/adfm.201804634
  140. Liu et al. (2017) Multifunctional metal–organic framework nanoprobe for cathepsin B-activated cancer cell imaging and chemo-photodynamic therapy (pp. 2150-2158) https://doi.org/10.1021/acsami.6b14446
  141. Zhu et al. (2019) Two-dimensional metal-organic-framework as a unique theranostic nano-platform for nuclear imaging and chemo-photodynamic cancer therapy (pp. 1307-1312) https://doi.org/10.1007/s12274-018-2242-2
  142. Luo et al. (2019) Light-induced redox-responsive smart drug delivery system by using selenium-containing polymer@MOF shell/core nanocomposite https://doi.org/10.1002/adhm.201900406
  143. Feng et al. (2019) Stimuli-responsive multifunctional metal-organic framework nanoparticles for enhanced chemo-photothermal therapy (pp. 994-1004) https://doi.org/10.1039/C8TB02815J
  144. Zeng et al. (2018) Porphyrinic metal–organic frameworks coated gold nanorods as a versatile nanoplatform for combined photodynamic/photothermal/chemotherapy of tumor https://doi.org/10.1002/adfm.201705451
  145. Ni et al. (2018) Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy https://doi.org/10.1038/s41467-018-06655-7
  146. Cai et al. (2020) Photodynamic therapy combined with antihypoxic signaling and CpG adjuvant as an in situ tumor vaccine based on metal–organic framework nanoparticles to boost cancer immunotherapy https://doi.org/10.1002/adhm.201900996
  147. Shao et al. (2020) Engineering of upconverted metal–organic frameworks for near-infrared light-triggered combinational photodynamic/chemo-/immunotherapy against hypoxic tumors (pp. 3939-3946) https://doi.org/10.1021/jacs.9b12788
  148. Gautam et al. (2022) Drug delivery of paracetamol by metal-organic frameworks (HKUST-1): improvised synthesis and investigations https://doi.org/10.1016/j.mtchem.2021.100647
  149. Wen et al. (2021) Versatile nanoscale metal-organic frameworks (nMOFs): an emerging 3D nanoplatform for drug delivery and therapeutic applications https://doi.org/10.1002/smll.202005064
  150. Li et al. (2020) Nanoscale metal - organic frameworks: synthesis, biocompatibility, imaging applications, thermal and dynamic therapy of tumors https://doi.org/10.1002/adfm.201908924
  151. Liu et al. (2021) Multifunctional metal-organic framework heterostructures for enhanced cancer therapy (pp. 1188-1218) https://doi.org/10.1039/D0CS00178C
  152. Liu et al. (2021) A multifunctional aminated UiO-67 metal-organic framework for enhancing antitumor cytotoxicity through bimodal drug delivery https://doi.org/10.1016/j.cej.2020.127899
  153. Liu et al. (2021) Recent advances in cell membrane coated metal-organic frameworks (MOFs) for tumor therapy (pp. 4459-4474) https://doi.org/10.1039/D1TB00453K
  154. Sepehrpour et al. (2019) Biomedically relevant self-assembled metallacycles and metallacages (pp. 14005-14020) https://doi.org/10.1021/jacs.9b06222
  155. Sun et al. (2020) Recent developments in the construction and applications of platinum-based metallacycles and metallacages via coordination (pp. 3889-3919) https://doi.org/10.1039/D0CS00038H